A Cyclic Phosphoramidate Prodrug of 2′-Deoxy-2′-Fluoro-2′- C -Methylguanosine for the Treatment of Dengue Virus Infection
Authors:
- 17 November 2020
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 64 (12)
Abstract
Monophosphate prodrug analogs of 2′-deoxy-2′-fluoro-2′- C -methylguanosine have been reported as potent inhibitors of hepatitis C virus (HCV) RNA-dependent RNA polymerase. These prodrugs also display potent anti-dengue virus activities in cellular assays although their prodrug moieties were designed to produce high levels of triphosphate in the liver. Since peripheral blood mononuclear cells (PBMCs) are among the major targets of dengue virus, different prodrug moieties were designed to effectively deliver 2′-deoxy-2′-fluoro-2′- C -methylguanosine monophosphate prodrugs and their corresponding triphosphates into PBMCs after oral administration.Keywords
All Related Versions
This publication has 47 references indexed in Scilit:
- The dengue virus NS5 protein as a target for drug discoveryAntiviral Research, 2015
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trialThe Lancet, 2014
- Ten years of dengue drug discovery: Progress and prospectsAntiviral Research, 2013
- Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseasesNature Reviews Drug Discovery, 2013
- The global distribution and burden of dengueNature, 2013
- Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infectionArchives of Virology, 2013
- Comparative Study of the Genetic Barriers and Pathways towards Resistance of Selective Inhibitors of Hepatitis C Virus ReplicationAntimicrobial Agents and Chemotherapy, 2011
- The pathogenesis of dengueVaccine, 2011
- Inhibition of Dengue Virus RNA Synthesis by an Adenosine NucleosideAntimicrobial Agents and Chemotherapy, 2010
- An adenosine nucleoside inhibitor of dengue virusProceedings of the National Academy of Sciences, 2009